Jefferies Group LLC Biohaven Pharmaceutical Holding CO Ltd. Put Options Transaction History

Jefferies Group LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2021 May 14, 2021	SELL	$64.07 - $91.75 $1.79 Million - $2.57 Million	-28,000 Closed	0 $0
Q4 2020 Sep 21, 2023	BUY	$65.07 - $98.24 $1.82 Million - $2.75 Million	28,000 New	28,000 $2.4 Million
Q1 2020 May 15, 2020	SELL	$27.51 - $57.29 $800,541 - $1.67 Million	-29,100 Reduced 50.96%	28,000 $0
Q4 2019 Feb 13, 2020	SELL	$40.86 - $57.65 $49,032 - $69,180	-1,200 Reduced 2.06%	57,100 $0
Q3 2019 Nov 13, 2019	BUY	$37.38 - $49.47 $1.81 Million - $2.4 Million	48,500 Added 494.9%	58,300 $0
Q2 2019 Aug 14, 2019	SELL	$39.79 - $67.01 $9.6 Million - $16.2 Million	-241,300 Reduced 96.1%	9,800 $0
Q1 2019 May 15, 2019	BUY	$34.52 - $53.29 $8.67 Million - $13.4 Million	251,100 New	251,100 $0

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.